Bernhard Sielaff

619 total citations
17 papers, 440 citations indexed

About

Bernhard Sielaff is a scholar working on Molecular Biology, Pharmacology and Materials Chemistry. According to data from OpenAlex, Bernhard Sielaff has authored 17 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Materials Chemistry. Recurrent topics in Bernhard Sielaff's work include Protein Structure and Dynamics (5 papers), Enzyme Structure and Function (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Bernhard Sielaff is often cited by papers focused on Protein Structure and Dynamics (5 papers), Enzyme Structure and Function (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Bernhard Sielaff collaborates with scholars based in United States and Germany. Bernhard Sielaff's co-authors include Francis Tsai, Sukyeong Lee, Jungsoon Lee, Jan R. Andreesen, John M. Matsen, Jihyun Kim, Amadeo B. Biter, Thomas Schräder, James E McKie and Eugene H. Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Bernhard Sielaff

17 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernhard Sielaff United States 13 318 95 69 61 36 17 440
D R Johnson United States 11 718 2.3× 117 1.2× 188 2.7× 36 0.6× 26 0.7× 12 907
D.P. Huddler United States 9 352 1.1× 56 0.6× 39 0.6× 15 0.2× 27 0.8× 10 491
Kayode S. Oyedotun Canada 11 357 1.1× 26 0.3× 61 0.9× 11 0.2× 28 0.8× 12 511
Vivi Joosten Netherlands 8 396 1.2× 34 0.4× 32 0.5× 27 0.4× 21 0.6× 9 607
Peter A. Chalk United Kingdom 15 348 1.1× 82 0.9× 90 1.3× 92 1.5× 27 0.8× 21 672
Edith Gollub United States 13 449 1.4× 37 0.4× 62 0.9× 27 0.4× 14 0.4× 27 582
R. Toro United States 15 393 1.2× 93 1.0× 20 0.3× 73 1.2× 10 0.3× 22 578
Yu Wai Chen United Kingdom 15 488 1.5× 167 1.8× 40 0.6× 50 0.8× 10 0.3× 48 705
Dominique Liger France 18 587 1.8× 145 1.5× 24 0.3× 41 0.7× 7 0.2× 29 750
T H Liao United States 13 306 1.0× 37 0.4× 42 0.6× 35 0.6× 4 0.1× 18 410

Countries citing papers authored by Bernhard Sielaff

Since Specialization
Citations

This map shows the geographic impact of Bernhard Sielaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Sielaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Sielaff more than expected).

Fields of papers citing papers by Bernhard Sielaff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Sielaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Sielaff. The network helps show where Bernhard Sielaff may publish in the future.

Co-authorship network of co-authors of Bernhard Sielaff

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Sielaff. A scholar is included among the top collaborators of Bernhard Sielaff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Sielaff. Bernhard Sielaff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Goenka, Radhika, Josue Samayoa, David Banach, et al.. (2021). CTLA4-Ig–Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function. The Journal of Immunology. 206(5). 1102–1113. 7 indexed citations
3.
Argiriadi, M.A., Lorenzo Benatuil, David A. Egan, et al.. (2019). CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches. BMC Molecular and Cell Biology. 20(1). 29–29. 19 indexed citations
4.
Zhou, Li, Viktor Todorović, Bernhard Sielaff, et al.. (2017). Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation. Journal of Biological Chemistry. 293(2). 403–411. 28 indexed citations
5.
Lee, Jungsoon, Jihyun Kim, Amadeo B. Biter, et al.. (2013). Heat shock protein (Hsp) 70 is an activator of the Hsp104 motor. Proceedings of the National Academy of Sciences. 110(21). 8513–8518. 87 indexed citations
6.
Sielaff, Bernhard, et al.. (2010). Structural and Functional Conservation of Mycobacterium tuberculosis GroEL Paralogs Suggests that GroEL1 Is a Chaperonin. Journal of Molecular Biology. 405(3). 831–839. 14 indexed citations
7.
Sielaff, Bernhard & Francis Tsai. (2010). The M-Domain Controls Hsp104 Protein Remodeling Activity in an Hsp70/Hsp40-Dependent Manner. Journal of Molecular Biology. 402(1). 30–37. 80 indexed citations
8.
Sielaff, Bernhard, et al.. (2010). Crystallization and preliminary X-ray crystallographic analysis of a GroEL1 fragment fromMycobacterium tuberculosisH37Rv. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 66(4). 418–420. 3 indexed citations
9.
Lee, Sukyeong, Bernhard Sielaff, Jungsoon Lee, & Francis Tsai. (2010). CryoEM structure of Hsp104 and its mechanistic implication for protein disaggregation. Proceedings of the National Academy of Sciences. 107(18). 8135–8140. 74 indexed citations
12.
Sielaff, Bernhard, Jan R. Andreesen, & Thomas Schräder. (2001). A cytochrome P450 and a ferredoxin isolated from Mycobacterium sp. strain HE5 after growth on morpholine. Applied Microbiology and Biotechnology. 56(3-4). 458–464. 19 indexed citations
14.
Barry, A L, T L Gavan, Peter B. Smith, et al.. (1982). Accuracy and precision of the autobac system for rapid identification of Gram-negative bacilli: a collaborative evaluation. Journal of Clinical Microbiology. 15(6). 1111–1119. 18 indexed citations
15.
Sielaff, Bernhard, John M. Matsen, & James E McKie. (1982). Novel approach to bacterial identification that uses the autobac system. Journal of Clinical Microbiology. 15(6). 1103–1110. 20 indexed citations
16.
Buck, G E, et al.. (1977). Automated, rapid identification of bacteria by pattern analysis of growth inhibition profiles obtained with Autobac 1. Journal of Clinical Microbiology. 6(1). 46–49. 6 indexed citations
17.
Sielaff, Bernhard, Eugene H. Johnson, & John M. Matsen. (1976). Computer-assisted bacterial identification utilizing antimicrobial susceptibility profiles generated by autobac 1. Journal of Clinical Microbiology. 3(2). 105–109. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026